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Determinarea marginii chirurgicale histologic 
sigure în cancerul pulmonar non-microcelular
Obiectiv: Recidivele locale ale tumorilor la limita 
rezecţiei chirurgicale reprezintă o problemă serioasă în 
rezecţiile pulmonare pentru cancer pulmonar. Obiectivul 
acestui studiu este identificarea marginilor interesate 
şi determinarea distanţelor sigure ale rezecţiei pentru 
prevenţia recidivelor locale. Materiale şi metodă: În acest 
studiu prospectiv au fost incluşi 66 de pacienţi operaţi 
pentru cancer pulmonar non-microcelular (NSCLC) între 
ianuarie 2006 şi septembrie 2008 în spitalul nostru terţiar. 
După efectuarea rezecţiilor pulmonare chirurgicale, s-au 
prelevat biopsii multiple la distanţe de tumoră de 5 mm 
(A), 10 mm (B), 15 mm (C) şi 20 mm (D). Specimenele au 
fost examinate histopatologic. Rezultate: Din totalul de 
66 de pacienţi cu NSCLC, 25 (38%) aveau adenocarcinom, 
18 (27,3%) carcinom epidermoid, 5 (7,5%) carcinom cu 
celule mari, 4 (6%) carcinom bronhioloalveolar, 4 (6%) 
carcinom adenoid chistic, 3 (4,6%) carcinoid malign şi 7 
(10,6%) metastaze. Cele mai obişnuite simptome erau 
dispneea şi tusea. Margini histopatologic pozitive au fost 
identificate la 84,8% din fragmente (A), 10,6% (B), 4,5% 
(C) şi 0% (D). A existat o diferenţă statistic semnificativă a 
interesării tumorale între distanţa de 5 mm (A) şi 10-20 mm 
(B-D) (p<0.001). Concluzie: O distanţă de 20 de mm faţă 
de masa tumorală este considerată o margine chirurgicală 
sigură în orice tip de rezecţie pulmonară pentru cancer 
pentru prevenirea recidivelor locale, în absenţa unui 
examen histopatologic anterior intervenţiei chirurgicale.
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Abstract Rezumat
Background and Aim: Local recurrences of the 
tumor at the surgical margin are serious problems 
in pulmonary resections for lung cancer. The aim of 
this study is to determine the involved margins and 
safe distances of the resection sites from tumor for 
prevention of local recurrences. Material and Methods: 
In this prospective study, 66 patients operated for 
non-small cell lung carcinoma (NSCLC) from Jan 
2006 to Sep 2008 were evaluated. After performing 
pulmonary resections, multiple biopsies were taken 
up from 5 mm (A), 10 mm (B), 15 mm (C), and 20 
mm (D) distance from tumor. The specimens were 
studied histopathologically. Results: From a total of 66 
patients with NSCLC admitted to our referral hospital, 
25 (38%) had adenocarcinoma, 18 (27.3%) squamous 
cell carcinoma, 5 (7.5%) large cell carcinoma, 4 (6%) 
bronchoalveolar cell carcinoma, 4 (6%) adenoid cystic 
carcinoma, 3 (4.6%)  malignant carcinoid tumor and 7 
(10.6%) had metastasis. The most common symptoms 
were dyspnea and cough. Histopathologically tumor 
positive margins were found in 84.8% (A), 10.6% 
(B), 4.5% (C), and 0% (D). There was a significant 
statistically difference between tumor involvement 
at distances 5 mm (A) versus 10-20 mm (B-D) (P 
<0.001). Conclusion: A 20 mm distance from the 
gross tumor is considered as a safe surgical margin 
in any type of malignant pulmonary resections 
for prevention of local surgical recurrences if there 
was no pathologic examination before surgery.
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Introduction
Pulmonary resections such as lobectomy and pneumonectomy 
are the gold standard treatment for pulmonary carcinomas in low 
stages. Segmentectomy and wedge resections are used only for 
patients with low residual pulmonary function1. Local recurrence 
in the surgical margin can be a serious problem in the surgery 
of pulmonary carcinoma2. Although safe surgical margins can 
be determined by frozen section sampling during surgery in the 
operating room, defining the safe margins from the tumor is 
necessary and important for surgeons in performing any type 
of pulmonary resections. Hence, there are still challenges in 
determining accurate safe surgical margin in the literature3, 4. 
In this study, we evaluated the surgical pathology of pulmonary 
specimens for determining the safe surgical margins to prevent 
probable local surgical recurrences. 
Material and Methods
 In a prospective study, 86 patients admitted for pulmonary 
carcinoma surgery from January 2006 to September 2008 at 
our referral hospital were evaluated. This study was approved 
by Medical Ethics of Tabriz University of Medical Sciences. 
Inclusion criteria (66 patients):
- Patients with non-small cell lung carcinoma (NSCLC) in 
stages I, II and IIIA;
- Operable metastatic pulmonary lesions.
Exclusion criteria (20 patients):
- Patients with NSCLC  in stages IIIB and IV;
- Cardiopulmonary co-morbidities.
Patients’ medical records were reviewed for symptoms, 
signs, radiographic imaging, diagnostic bronchoscopy, pul-
monary function tests, staging mediastinoscopy and surgical 
managements.
Based on the results of the pathologic examination, the 
samples were divided into four groups, as follows: 
- Group A: Tumoral involvement 0-5 mm from the tumor;
- Group B: Tumoral involvement 5-10 mm from the tumor; 
- Group C: Tumoral involvement 10-15 mm from the tu-
mor; 
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- Group D: Tumoral involvement 15-20 mm from the tu-
mor. 
Samples reported to have tumoral cells in microscopic pa-
thological examination were considered as positive results. 
The obtained data were collected and analyzed.
Statistical analysis
The endpoints of the present study were to determine the 
safe surgical margins pathologically for NSCLC specimens. 
Data were presented as Mean± SD & N (%). Variables were 
analyzed with the independent sample T test for continuous 
variables and Chi-square or Fisher Exact test for nominal 
or ordinal variables. P-value less than 0.05 were considered 
statistically significant. The statistical package for social 
science (SPSS 16) was used for statistical analysis.
Results
 There were a total of 66 patients with NSCLC, 40 (60.6%) 
males and 26 (39.4%) females with mean ages of 55 ± 4.0 and 
64 ± 3.0 years. The types of tumors were adenocarcinoma in 
25 cases (38%), squamous cell carcinoma (SCC): 18 (27.3%), 
large cell carcinoma: 5 (7.5%), bronchoalveolar cell carcinoma: 
4 (6%), adenoid cystic carcinoma: 4 (6%), malignant carcinoid 
tumor: 3 (4.6%), and metastasis: 7 (10.6%). 
The most common symptoms of the patients were pulmo-
nary distress and dyspnea in 30 (45.5%) patients, cough in 20 
(30.3%) patients, chest pain in 10 (15.15%) patients, hemop-
tysis in 4 (6%) patients), asymptomatic 2 (3%) patients. 
Two to three centimeter distance away from the tumors was 
the usual distance where we performed pulmonary resections. 
In all 66 patients, 4 samples were examined at distances of 
5, 10, 15 and 20 mm from gross tumor. From all samples 
(66x4=264 samples), a number of 198 were found positive 
(75%). The positive samples were distributed in the following 
distance groups:
- A (5 mm): 56 positive samples (84.8% of 66);
- B (10 mm): 7 positive samples (10.7% of 66);
- C (15 mm): 3 positive samples (4.5% of 66);
- D (20 mm): 0 positive samples (0%).
Table I shows the types of lung carcinomas in relation to 
safe surgical margins.
Differences in distribution of tumor involvement in distan-
ces up to 5 mm and 5-20 mm were statistically significant as 
distances until 5 mm were mostly affected by tumor (totally 
84.8%), while margins in distances from 5 mm to <20 mm 
were affected rarely (15.2%) and margins in distances of 20 
mm were not affected by tumor (0%) (P <0.001).
Discussion
Local recurrences of postsurgical stumps are due to the 
presence of occult retained tumoral cells in surgical margins. 
Patients with positive margins have significantly worse local 
regional control than those with negative margins2, 5. Despite 
complete resection, up to 20% to 30% of patients will deve-
lop recurrence disease. Recurrence following lung resection 
predominantly is influenced by tumor size, invasion to lym-
phatic and capillaries, and tumor infiltration. Optimization 
of surgical margins is one of the factors that may improve 
outcome. Sublobar resection demonstrates high local recur-
rence in comparison with lobectomy patients6, 7. Yano and 
colleagues reported 40/471 (8.5%) local recurrences and they 
also mentioned that survival of the patients was improved 
by adding radiation protocol8.
Ginsberg’s randomized trial study showed 8/247 local re-
currences in lobectomy patients in comparison with 21/247 
local recurrences in sublobar patients in the treatment of 
T1N0M0 stage. In the retrospective study of Sherif, it was 
shown that 7-year survival rate of the disease free patients 
was equal between lobectomy and sublobar resection patients 
in stage IA, NSCLC and if all stage I, NSCLC tumors were 
included in the analysis, lobar patients had significantly 
better results than sublobar patients9, 10.
Sienel and colleagues studied the frequency of local re-
currence following segmentectomy (49 patients) in stage 
IA, NSCLC and reported 6% recurrence in segmentectomy 
patients which was more frequent than in lobectomy pati-
ents (5%). In their performed operations, segmentectomy 
in the region of S1-3 had more local recurrences (23%) 
than segmentectomy in the S7-8 regions (12%) and re-
section margin ≤1 cm tended to be associated with local 
recurrences11. We did not compare the segmentectomy 
and lobectomy specimens; however, the specimens were 
compared totally with the surgical pathologic distances 
from the tumor.
 Goldstein and Maygarden reported that a 30 mm dis-
tance from the gross tumor is the surgical safe margin. 
Goldstein also reported a 7 mm distance from the tu-
mor for performing wedge resections of adenocarcinoma 
and a 24 mm distance was the safe margins in lobectomy 
patients4, 12. Kara and colleagues in Turkey, in a study on 
70 patients reported that a 15 mm distance from the tumor 
was the safe margin in 93% patients of NSCLC13. Their study 
revealed a statistically significant difference in relation to loco 
regional recurrence between lobectomy and segmentectomy 
patients. In the Mahesh study, it was reported that distances 
more than 20 mm are the safe surgical margins which is simi-
lar to the results of our study3. Ketchedjian in a parallel study, 
reported the 10 mm distance as the safe surgical margin in the 
distances 10 mm emphasizing the fact that  margins more than 
10 mm had lower surgical stump recurrences14.  
Type of tumor A = 5 mmN(%)
B = 10 mm
N(%)
C = 15 mm
N(%)
Adenocarcinoma 20 (80) 5 (20) 0 (0)
Squamous cell carcinoma 18 (100) 0 (0) 0 (0)
Large cell carcinoma 0 (0) 2 (40) 3 (60)
Bronchoalveolar carcinoma 4 (100) 0 (0) 0 (0)
Adenoid cystic carcinoma 4 (100) 0 (0) 0 (0)
Metastasis 7 (100) 0 (0) 0 (0)
Malignant carcinoid 3 (100) 0 (0) 0 (0)
*No patient had D= 20 mm
Types of lung carcinomas in relation to safe 
surgical margins (n = 66)
Table I
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Masayesava in Canada reported a 4 mm distance as the 
safe surgical margin2. Tanggitgarnel’s experience in resection 
of pulmonary metastasis revealed that the safe margin is a 
prognostic factor, in our study the prognostic factor was 5 
mm15.
Lee et al recommended limited resections to be accepted in 
peripheral lesions with tumor sizes less than 30 mm16. Wedge 
and segmental resections are recommended in old and stage 
IA patients with low pulmonary function tests6, 17.
To prevent loco regional recurrences, we proposed that 
20 mm, 15 mm, and 10 mm distances were the safe surgi-
cal margins for large cell carcinoma, adenocarcinoma, and 
squamous cell carcinoma of the lung. Safe surgical margins 
for bronchoalveolar, adenoid cystic carcinomas, malignant 
carcinoid tumors, and metastasis of the lung must be at 
least 5 mm.
Totally, in the surgery of NSCLC, metastases had lowest 
safe surgical margins (5 mm), and large cell carcinoma of the 
lung had the maximum safe surgical margin (20 mm).
Recently video assisted thoracoscopic surgery (VATS) is 
being used in segmentectomy and wedge resections. In pa-
tients with limited pulmonary function tests we performed 
wedge or segmental resections especially in metastasis and 
none of them were performed through VATS. In one cohort 
study, 5-year survival of the patients having undergone open 
wedge resection was 58% less than VATS wedge resections 
and classic standard pulmonary resections had prolonged 
survival2, 3, 18.  
Conclusion
A 20 mm distance from the gross tumor is considered as 
a safe surgical margin in any type of malignant pulmonary 
resections for prevention of local surgical recurrences if there 
is no pathologic examination before surgery. However, in 
patients with bronchoalveolar, cystic adenomatoid carcino-
ma, malignant carcinoid tumors and metastasis greater than 
5 cm distance from the gross tumor can be considered as a 
safe surgical margin. 
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